PPT-Intralipid® Therapy for Recurrent Pregnancy Loss – Controversies and Future Directions

34 th Annual Meeting of the American Society for Reproductive Immunology June 25 2014 Jeffrey Braverman MD FACOG Intralipid What is it Fat emulsion containing soybean oil glycerin . Is Aneuploidy the only answer ?. Ruth B Lathi, MD. Associate Professor. Director of Recurrent Pregnancy Loss. Disclosures. I have no financial disclosures. Impact of miscarriage. Picture of Patients. Dr Chro Najmaddin Fattah. MBChB, DGO, MRCOG, MRCPI, MD. introduction. Miscarriage is defined as the spontaneous loss of pregnancy before the fetus reaches . viability.. T. herefore . includes all pregnancy losses from the time of conception until 24 weeks of gestation. History of Present Illness. 26 F with . Crohn’s. disease. Developed persistent diarrhea in 2008. colonoscopy demonstrated . Crohn's. disease primarily involving terminal ileum but also some active colitis in the sigmoid colon. . Joseph . B. Stanford, MD, . MSPH, CFCMC. Professor. Family and Preventive Medicine, Obstetrics and Gynecology, and Pediatrics. University of Utah. Outline. Terms: conception. Stages of pregnancy and loss. A Amouzegar MD. Endocrine Research Center. Research Institute For Endocrine Sciences. Outlines. Causes of hyperthyroidism. Consequences of hyperthyroidism. Consequence of poor control . The treatment of . Professor and Head. Dept. Obstetrics and Gynaecology. SKHMC Kulasekharam. Abortion . Abortion. Loss of a pregnancy during the first 20 weeks of pregnancy, or if the weight is 500gms or less, at a time that the fetus cannot survive. . of three or more consecutive pregnancy losses at ≤ 20 weeks or. with a fetal weight < 500 . grams. Recurrent miscarriage should be distinguished from sporadic pregnancy loss that implies intervening pregnancies that reached viability. Maggie Donovan, PA-S2. University of South Dakota . Physician Assistant Studies Program. Recurrent pregnancy loss (RPL) is an important issue in reproductive health and is commonly defined as two or more clinically recognized failed pregnancies before 20 weeks of gestation. Recurrent pregnancy loss has been found to affect 1%-5% of couples trying to conceive and the mechanism of nearly 50% of cases of RPL remains unknown. Generally accepted mechanisms of RPL include uterine abnormalities, immunologic factors such as antiphospholipid antibody syndrome, and genetic abnormalities. Some hypothesized mechanisms that remain controversial are endocrine factors, inherited thrombophilia disorders, paternal sperm abnormalities, infections, environmental, and psychological factors. This review evaluates past and current research to assess which mechanisms are empirically supported as underlying causes of recurrent pregnancy loss. . . Update 2022. DEFINITION . . Pregnancy loss (miscarriage); . Spontaneous demise of a pregnancy before the fetus reaches viability(until 24 GA). . “Recurrent” pregnancy loss; . loss of two or more pregnancies. DR.A.SAMSAMI . DEPARTMENT OF OB GYN. Shiraz University of Medical Sciences. SHIRAZ – IRAN. . . A pregnancy loss . (miscarriage) . is defined as the spontaneous demise of a pregnancy before the fetus reaches viability. The term therefore includes all pregnancy losses (PLs) from the time of conception until 24 weeks of gestation. . Clinical questions . list:. 1-what is the effect . of pregnancy on . prolactinoma. . size?. 2-What is the . management . of . prolactinoma. in pregnancy. ?. 3-When does . prolactinoma. be treated during pregnancy. Vol.10; Issue: 12; December 2020 Website: www.ijhsr.org Case Report ISSN: 2249 - 9571 Inter national Journal of Health Science s and Research (www.ijhsr.org ) 270 Vol.10; Issue: 12; December 2020 ECTOPIC PREGNANCY. DR. RAZAQ . MASHA,FRCOG. Assistant Professor & Consultant. Department of Obstetrics & Gynecology. An abortion is pregnancy that ends before the baby can survive outside the uterus because it has not yet reached viability. It is therefore defined as a spontaneous loss of a pregnancy before 24 weeks. An abortion tends to start with bleeding and pain may develop.. Jean Anderson, MD. Professor, Director of Division of Gynecologic Specialties. The Johns Hopkins University. Baltimore, MD. Financial Relationships With Ineligible Companies (Formerly Described as Commercial Interests by the ACCME) Within the Last 2 Years.